SCHEMBL3886895

SCHEMBL3886895

CCOC(=O)C(=O)C1CSCC(=Cc2ccc(F)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
CYP1A2 P05177 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 4/20 0.42
STAT3 P40763 1/20 0.39
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
HSD11B1 P28845 2/20 0.36
PPARG P37231 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
MDM2 Q00987 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13867288 1.00 MAPT (0.45) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL645065 0.83 ALDH1A1 (0.48) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL645064 0.83 ALDH1A1 (0.48) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL2719545 0.81 ALDH1A1 (0.46) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL182255 0.81 ALDH1A1 (0.46) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL182254 0.81 ALDH1A1 (0.46) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL176973 0.80 NPC1 (0.48) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL13411537 0.80 MAPT (0.47) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL2847136 0.80 MAPT (0.47) MAPTCYP1A2MEN1KMT2ANPSR1
SCHEMBL13745233 0.80 NPC1 (0.48) MAPTCYP1A2MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524964-B2 Tetrahydrothiopyrano pyrazole cannabinoid modulators JANSSEN PHARMACEUTICA NV (BE) 2009-04-28 US disclosed
US-20080085899-A1 TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS LIOTTA FINA 2008-04-10 US disclosed
US-20060223798-A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators JANSSEN PHARMACEUTICA NV (BE) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223798-A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators CNR1, CNR2, GPR18 MAPT 1971/4885CYP1A2 507/4885MEN1 4352/4885
US-20080085899-A1 TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS CNR1, CNR2, GPR18 MAPT 1971/4885CYP1A2 507/4885MEN1 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.